Health

FDA Cries Foul Over Kim Kardashian's Medication Promotion

| by Michael Allen

The Food and Drug Administration (FDA) has recalled an Instagram picture posted by Kim Kardashian in July.

Kardashian's Instagram picture showed the reality TV star holding a bottle of DICLEGIS.

Popular Video

Everyone, meet Madeline Stuart. She's the first-ever professional model with Down Syndrome, and she's inspiring millions of people around the world:

According to the FDA, Kardashian also included a caption that stated: "OMG. Have you heard about this? As you guys know my #morningsickness has been pretty bad. I tried changing things about my lifestyle, like my diet, but nothing helped, so I talked to my doctor. He prescribed me #Diclegis, and I felt a lot better and most importantly, it’s been studied and there was no increased risk to the baby."

"I’m so excited and happy with my results that I’m partnering with Duchesnay USA to raise awareness about treating morning sickness. If you have morning sickness, be safe and sure to ask your doctor about the pill with the pregnant woman on it and find out more (two websites listed)."

Popular Video

Everyone, meet Madeline Stuart. She's the first-ever professional model with Down Syndrome, and she's inspiring millions of people around the world:

The FDA's Office of Prescription Drug Promotion (OPDP) sent a letter on August 7 to the drug manufacturer, Duchesnay, which said: "The social media post is misleading because it presents various efficacy claims for DICLEGIS, but fails to communicate any risk information."

The FDA letter did mention the websites that were posted at the end of Kardashian's message, but added: "By omitting the risks associated with DICLEGIS, the social media post misleadingly fails to provide material information about the consequences that may result from the use of the drug and suggests that it is safer than has been demonstrated."

The Instagram posting has been taken down.

Duchesnay told CNBC that Kardashian was paid (by Duchesnay) to plug her use of DICLEGIS, which she found through her doctor.

"Duchesnay is working very hard to take quick action in responding to the FDA’s letter and are working out a plan to submit to the FDA," Laney Landsman, a spokeswoman for Duchesnay, told The Washington Post.

However, if Kardashian had not been paid by Duchesnay, then she could have promoted DICLEGIS without any medical disclaimers.

Sources: Instagram, The Washington Post, CNBC, FDA.gov / Photo Credit: Instagram Screenshot